TABLE 1.
Suggested broth microdilution breakpoints for rapidly growing mycobacteriaa
| Drug | MIC (μg/ml) for category:
|
||
|---|---|---|---|
| Susceptible | Intermediate | Resistant | |
| Amikacinb | ≤16 | 32 | ≥64 |
| Cefoxitin | ≤16 | 32 [32–64] | ≥64 [≥128] |
| Ciprofloxacinb | ≤1 | 2 | ≥4 |
| Clarithromycinb | ≤2 | 4 | ≥8 |
| Doxycycline | ≤1 | 2–8 | ≥16 |
| Imipenemb | ≤4 | 8 | ≥16 |
| Sulfamethoxazolebc | ≤32 | ≥64 | |
| Tobramycin (M. chelonae only) | ≤4 | 8 | ≥16 |
Breakpoints recommended by the American Society for Microbiology Clinical Procedures Handbook (3). Proposed new breakpoints are in brackets.
NCCLS recommended breakpoint for bacteria that grow aerobically (8a).
NCCLS recommendations are for trimethoprim-sulfamethoxazole at similar but not identical concentrations.